Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 762178, 11 pages
http://dx.doi.org/10.1155/2015/762178
Clinical Study

Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines

1Research Unit in Biomedicine and Translational Oncology, Vall d’Hebron Research Institute and Hospital and Autonomous University of Barcelona, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain
2Department of Urology, Vall d’Hebron University Hospital and Autonomous University of Barcelona, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain
3Departament de Ciències Bàsiques, Universitat Internacional de Catalunya, Josep Trueta s/n, Sant Cugat del Vallès, 08195 Barcelona, Spain
4Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l’Hospitalet 199, 08907 Barcelona, Spain
5Department of Pathology, Vall d’Hebron University Hospital and Autonomous University of Barcelona, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain

Received 5 June 2014; Accepted 18 September 2014

Academic Editor: Jeremy Clark

Copyright © 2015 M. Olivan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

M. Olivan, M. Rigau, E. Colás, et al., “Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines,” BioMed Research International, vol. 2015, Article ID 762178, 11 pages, 2015. https://doi.org/10.1155/2015/762178.